Anti-prion antibodies for prophylaxis following prion exposure in mice

Neuroscience Letters

Volumn 336, Issue 3, 2003, Pages 185-187

  Sigurdsson, Einar M ^a   Sy, Man Sun ^b   Li, Ruliang ^b   Scholtzova, Henrieta ^a   Kascsak, Richard J ^c   Kascsak, Regina ^c   Carp, Richard ^c   Meeker, Harry C ^c   Frangione, Blas ^a   Wisniewski, Thomas ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Antibodies; Passive immunization; Prion; Treatment; Vaccination

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 8B4; MONOCLONAL ANTIBODY 8F9; MONOCLONAL ANTIBODY 8H4; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG PROTEIN BINDING; FEMALE; INCUBATION TIME; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRION DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME;

EID: 0037461583     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01192-8     Document Type: Article

References (13)

1. Aucouturier P., Carp R.I., Carnaud C., Wisniewski T. Prion diseases and the immune system. Clin. Immunol. 96:2000;79-85.
2. Diedrich J.F., Bendheim P.E., Kim Y.S., Carp R.I., Haase A.T. Scrapie associated prion protein accumulates in astrocytes during scrapie infection. Proc. Natl. Acad. Sci. USA. 88:1991;375-379.
3. Enari M., Flechsig E., Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA. 98:2001;9295-9299.
4. Fraser J.R. What is the basis of transmissible spongiform encephalopathy induced neurodegeneration and can it be repaired? Neuropathol. Appl. Neurobiol. 28:2002;1-11.
5. Heppner F.L., Musahl C., Arrighi I., Klein M.A., Rulicke T., Oesch B., Zinkernagel R.M., Kalinke U., Aguzzi A. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science. 294:2001;178-182.
6. Kascsak R.J., Fersko R., Pulgiano D., Rubenstein R., Carp R.I. Immunodiagnosis of prion disease. Immun. Invest. 26:1997;259-268.
7. Liu T., Zwingman T., Li R., Pan T., Wong B.S., Petersen R.B., Gambetti P., Herrup K., Sy M.S. Differential expression of cellular prion protein in mouse brain as detected with multiple anti-PrP monoclonal antibodies. Brain Res. 896:2001;118-129.
8. Pedersen N.S., Smith E. Prion disease: epidemiology in man. APMIS. 110:2002;14-22.
9. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Dwek R.A., Burton D.R., Prusiner S.B. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 412:2001;739-743.
10. Prusiner S.B. Neurodegenerative diseases and prions. N. Engl. J. Med. 344:2001;1516-1526.
11. Sethi S., Lipford G., Wagner H., Kretzschmar H. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet. 360:2002;229-230.
12. Sigurdsson E.M., Brown D.R., Daniels M., Kascsak R.J., Kascsak R., Carp R.I., Meeker H.C., Frangione B., Wisniewski T. Vaccination delays the onset of prion disease in mice. Am. J. Pathol. 161:2002;13-17.
13. Soto C., Kascsak R.J., Saborio G.P., Aucouturier P., Wisniewski T., Prelli F., Kascsak R., Mendez E., Harris D.A., Ironside J., Tagliavini F., Carp R.I., Frangione B. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides. Lancet. 355:2000;192-197.